Search

Search Results

• 

  Psoriatic arthritis: treatment strategies using biologic agents

  S. D'Angelo, C. Palazzi, I. Olivieri

  113-121

  05-06-2012

  Published: 5 June 2012

  1108

  PDF: 1133
• 

  Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

  J. Mencarini, M. Spinicci, F. Bartalesi

  144-147

  16-12-2016

  Published: 16 December 2016

  1529

  PDF: 1049
• 

  Psoriatic arthritis. When the heterogeneity requires normality

  L. Punzi, R. Ramonda

  59-65

  05-06-2012

  Published: 5 June 2012

  736

  PDF: 658

• BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

  D.D. Gladman

  85-87

  Published:

  601

  PDF: 539

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  3-7

  Published:

  1097

  PDF: 710

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  Published:

  1810

  PDF: 1103
• 

  Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

  I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

  1-3

  28-03-2013

  Published: 28 March 2013

  2235

  PDF: 685

• IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES

  S. Loffredo, F. Ayala, G.C. Marone, A. Genovese, G. Marone

  28-39

  Published:

  894

  PDF: 709
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  Published: 19 November 2020

  1401

  PDF: 949

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  31-38

  Published:

  1744

  PDF: 2483
• 

  Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

  F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

  52-59

  10-04-2020

  Published: 10 April 2020

  1684

  PDF: 998

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  30-33

  Published:

  1080

  PDF: 844

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  Published:

  961

  PDF: 664